Durable coexistence of donor and recipient strains after fecal microbiota transplantation

Citations Over TimeTop 1% of 2016 papers

Abstract

Fecal microbiota transplantation (FMT) has shown efficacy in treating recurrent Clostridium difficile infection and is increasingly being applied to other gastrointestinal disorders, yet the fate of native and introduced microbial strains remains largely unknown. To quantify the extent of donor microbiota colonization, we monitored strain populations in fecal samples from a recent FMT study on metabolic syndrome patients using single-nucleotide variants in metagenomes. We found extensive coexistence of donor and recipient strains, persisting 3 months after treatment. Colonization success was greater for conspecific strains than for new species, the latter falling within fluctuation levels observed in healthy individuals over a similar time frame. Furthermore, same-donor recipients displayed varying degrees of microbiota transfer, indicating individual patterns of microbiome resistance and donor-recipient compatibilities.

Related Papers

• → Fecal Microbiota Transplantation in Children With Recurrent Clostridium difficile Infection(2014)39 cited
• → A Practical Method for Preparation of Fecal Microbiota Transplantation(2016)16 cited
• → Sa1245 Physician Outlook Towards Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium difficile Infection(2013)1 cited
• → Projected Cost Savings of Introducing fecal Microbiota Transplant Treatment for Clostridium Difficile Infection In Canada(2015)
• → Peer Review #1 of "Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children (v0.1)"(2018)